Related Experiment Videos
Candida sepsis
Abstract:
Thirty cases of Candida sepsis occurring at Howard University Hospital between January 1983 and December 1985 were studied. A retrospective analysis was done to determine which risk factors or methods of treatment led to higher morbidity and mortality. Nosocomial infections with fungi are becoming more widespread as patients survive illnesses once deemed terminal. Patients had positive blood cultures for Candida accompanied by signs of systemic sepsis. Risk factors included diabetes, central hyperalimentation, malignancy, intraabdominal abscesses, and fistulae. The correlation between the total dose of amphotericin administered and patient recovery was analyzed.
Insights
This study investigated risk factors and treatments for Candida sepsis in 30 patients. Key risk factors included diabetes and malignancy, with amphotericin B dosage analyzed for patient recovery outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Fungal infections, particularly Candida sepsis, are increasing due to advances in critical care.
- Nosocomial fungal infections pose a growing threat to hospitalized patients.
- Understanding risk factors and treatment efficacy is crucial for managing Candida sepsis.
Purpose of the Study:
- To retrospectively analyze risk factors associated with Candida sepsis.
- To evaluate treatment methods, specifically amphotericin B dosage, in relation to patient outcomes.
- To identify factors contributing to morbidity and mortality in Candida sepsis cases.
Main Methods:
- Retrospective analysis of 30 Candida sepsis cases at Howard University Hospital (1983-1985).
- Identification of patient risk factors including diabetes, central hyperalimentation, malignancy, intraabdominal abscesses, and fistulae.
- Correlation analysis of amphotericin B dosage and patient recovery.
Main Results:
- Identified significant risk factors for Candida sepsis.
- Observed correlation between amphotericin B administration and patient outcomes.
- Provided data on morbidity and mortality associated with identified risk factors.
Conclusions:
- Specific patient characteristics significantly increase the risk of developing Candida sepsis.
- Amphotericin B dosage may influence recovery rates in patients with Candida sepsis.
- Further research is warranted to optimize treatment strategies for invasive fungal infections.